Albemarle to Start Producing Phosphorus-Based Flame Retardants in China

Resin makers who supply the electronic enclosures market will soon be able to get one of the world's best performing phosphorus flame retardants from a new production source.

To more efficiently meet global demand for its phosphorus-based NcendX(R) P-30 flame retardant, Albemarle Corporation will start up a new production unit in Nanjing, China, in the second quarter of 2008.

"This new plant will improve Albemarle's flexibility to supply our Asian customers as well as the rest of our global customer base for this important and growing flame retardant," said Luc Van Muylem, vice president of polymer additives.

The initial capacity of the new flame retardant plant will be 4,000 metric tons per year with options to expand at a later date.

Albemarle's existing NcendX P-30 flame retardant unit in Orangeburg, S.C. will be converted to other uses following startup of the Nanjing plant.

"We look forward to serving our global customer base from the new facility in Nanjing, which will provide the same, high-quality product as our Orangeburg facility does today," said Troy DeSoto, global business manager for NcendX P-30 flame retardant.

NcendX P-30 bisphenol A diphosphate-type (BPADP) flame retardant is an outstanding performer in resin blends used in electronic enclosure plastics such as PC/ABS and PPE/HIPS. NcendX P-30, a liquid flame retardant, is preferred over other phosphorus flame retardants because it improves resin melt flow and exhibits outstanding thermal stability, excellent hydrolytic stability, low migration and low volatility during processing and end use.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.